Medical Knowledge Sharing

Medical

UK Launches First Clinical Trial Of Proton Beam Therapy For Breast Cancer To Help Patients Reduce The Risk Of Heart Problems Caused By Radiotherapy

The clinical trial (PARABLE) will take place at 22 sites across the UK and is planned to recruit 192 patients at higher risk of developing heart problems. the PARABLE trial is led by researchers from the Royal Marsden Hospital, the University of Cambridge, and the Institute of Cancer Research (ICR) UK, and is managed by the Clinical Trials and Statistics Unit, funded by Cancer Research UK, at the Institute of Cancer Research (ICR). was conducted.

Medical

Cutting-Edge Targeted Drug For Cholangiocarcinoma Significantly Extends Patients' Lives!

Bile duct cancer is a rare but highly malignant tumour that occurs in the human bile duct system and has long had a poor prognosis. Now, researchers at University College London and University College London Hospitals, in an international multi-centre trial, have identified potentially good treatments that may radically improve the lives of some patients with bile duct cancer.

Apparatus

Airway Announces First Patient To Receive Dose In Bpd Trial

Biopharmaceutical company Airway has announced that the first patient will be administered AT-100 (rhSP-D) in a phase 1b randomised trial to prevent the risk of bronchopulmonary dysplasia (BPD) in very preterm infants. The novel prophylactic AT-100 reduces the incidence and severity of the severe respiratory disease BPD and may improve the prognosis of very preterm infants.

Medical

Approved! With Just One Oral Dose Per Day, This Type Of Breast Cancer Patient Gets a New Drug

The US FDA has approved Elacestrant, the first oral selective estrogen receptor degrader (SERD), for the treatment of patients with advanced or metastatic breast cancer who are estrogen receptor positive, HER2 negative and have an ESR1 mutation. Results of the trial showed that patients treated with Elacestrant had a 45% reduction in the risk of disease progression or death.

Medical

K-Drug Approved For Adjuvant Treatment Of Early-Stage Non-Small Cell Lung Cancer, Significantly Extending Cancer-Free Survival Of Patients!

The US FDA has approved pablizumab (Keytruda) as an adjuvant treatment for early-stage non-small cell lung cancer. In the trial, pablizumab (Keytruda) significantly prolonged cancer-free survival in patients compared to placebo.

Disease

What Are The Diets And Contraindications For Liver Cancer Patients? How Can Liver Cancer Be Prevented?

We all know that we need to pay attention to our diet after suffering from a disease, because improper diet will affect the recovery of the disease and the health of the patient.

Medical

Car-T Therapy Ide-Cel For Multiple Myeloma Prolongs Patient Survival By 2-Fold!

For patients with relapsed and refractory multiple myeloma, the CAR-T cell therapy Ide-cel resulted in a two-fold increase in the average length of time that patients' tumours did not progress compared to standard treatment, with 71% of patients experiencing substantial tumour regression and 39% experiencing complete tumour disappearance.

Disease

What Are The Side Effects Of Radiotherapy For Prostate Cancer? What Should Patients With Prostate Cancer Be Aware Of?

There are many ways to treat prostate cancer and radiation therapy is a common treatment for prostate cancer, but many prostate cancer patients want to know what the side effects of radiation therapy are.

Healthy

How can patients with poor heart survive the summer?

The continuous high temperature and hot weather in summer can not be ignored for people with cardiovascular diseases. Once they relax their vigilance, heart failure is very likely to occur, and heart failure is the end stage of various heart diseases, known as the stumbling block of life, which seriously endangers life and health.

Medical

Breast Cancer: a Brighter Future For Patients As New Cutting-Edge Drugs Continue To Emerge!

With more and more new cutting-edge drugs emerging, the standard treatment paradigm for breast cancer is now rapidly changing, and the future is looking brighter for patients.